News

Researchers at the University of California, Davis, have found that people may not recognize that their dog is stressed when exposed to common household noises.

A team from St. Jude Children’s Research Hospital has discovered the primary target of the experimental cancer drug CX-5164, revealing a possible risk for late effects of treatment.

A team of researchers has shown for the first time that cellular senescence is caused by irreversible damage to the genome rather than simply by telomere erosion.

Research has found that mindful awareness is about both accepting and engaging with life’s challenges, and that’s what popularized concepts of mindfulness tend to miss.

Levels of dopamine and the placebo effect can determine whether patients with social anxieties improve when treated with SSRIs. A new study shows the effect was four times higher for patients with high expectations of the medication compared with patients with low expectations.

A genetic predisposition for depression combined with exposure to high-particulate-matter air pollution greatly elevates the risk that healthy people will experience depression, according to a first-of-its-kind study.

A team of researchers report that before soluble fibrinogen is converted into insoluble fibrin molecules that can adversely accumulate, it can connect directly with neurons and cause a damaging inflammatory reaction.

A lot of people suddenly became more sedentary during the onset of the pandemic. Recent research found people who continued to spend a higher amount of time sitting between April and June 2020 were likely to have higher symptoms of depression. A closer investigation into this association could play a role in helping people improve their mental health.

Epilepsy and autism spectrum disorders, or ASD, show a remarkable degree of comorbidity and may share pathological mechanisms. Does autism lead to an increase in epilepsy? Or does epilepsy alter the brain circuit, which then leads to autism? A new paper has tackled these persistent questions.

The Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU) at Washington University School of Medicine in St. Louis has announced that it will be targeting two key Alzheimer’s proteins – amyloid and tau – as part of its Tau Next Generation Alzheimer’s prevention trial.